Research To Practice відкриті
[search 0]
більше

Download the App!

show episodes
 
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.
 
The official podcast of the Australasian Society for Intellectual Disability (ASID). We bring you the latest in Australian and New Zealand research into improving the rights and quality of life for people with intellectual disability. Find out more about ASID at our website http://asid.asn.au/ or follow us on social media: Twitter @ASID_Ltd Facebook: @asid.asn.au .
 
Loading …
show series
 
Featuring perspectives from Ms Jamie Carroll, Dr Sara Hurvitz, Ms Kelly Leonard and Dr Hope Rugo, including the following topics: Introduction (0:00) High-Risk Localized ER-Positive, HER2-Negative Breast Cancer (5:07) ER-Positive Metastatic Breast Cancer (28:06) Localized HER2-Positive Breast Cancer (49:15) Metastatic HER2-Positive Breast Cancer (1…
 
Featuring perspectives from Ms Kathy Burns, Dr Robert Dreicer, Dr Sandy Srinivas and Mr Ronald Stein, including the following topics: Introduction (0:00) PSA-Only Recurrence (M0 Disease) (10:45) Metastatic Hormone-Sensitive Prostate Cancer (35:07) Metastatic Castration-Resistant Prostate Cancer (BRCA Wild Type) (48:48) Metastatic Castration-Resista…
 
Featuring perspectives from Dr Ross Camidge, including the following topics: Introduction: First-line systemic treatment; brain metastases (0:00) Case: A woman in her early 60s with squamous NSCLC metastatic to tbe brain and an ALK rearrangement; PD-L1 TPS 70% — Spencer Henick Bachow, MD (20:30) Case: A man in his early 70s with localized NSCLC wit…
 
Featuring perspectives from Drs Tanios Bekaii-Saab and Philip Philip, including the following topics: Introduction (0:00) Treatment for Hepatocellular Carcinoma (14:52) Management of Biliary Tract Cancers (36:08) Clinical Decision-Making for Patients with Pancreatic Cancer (47:28) CME information and select publications…
 
Featuring an interview with Dr David O'Malley, including the following topics: Efficacy and safety data with mirvetuximab soravtansine for ovarian cancer (OC) from the SORAYA trial (0:00) Potential integration of mirvetuximab soravtansine into clinical practice; biologic rationale for and mechanism of action of upifitamab rilsodotin in therapy for …
 
Featuring a slide presentation and related discussion from Dr David O'Malley, including the following topics: Updates on ovarian cancer from the 2022 SGO Annual Meeting on Women’s Cancer (0:00) Updates from clinical trials evaluating PARP inhibitors alone or in combination as neoadjuvant, adjuvant and maintenance therapy (7:25) Emerging data and on…
 
Featuring perspectives from Dr Jennifer Brown, including the following topics: Introduction (0:00) Case: A man in his late 60s with chronic lymphocytic leukemia (CLL) on observation for 10 years who develops angioedema — G Richard Polkinghorn, MD (9:11) Case: A woman in her early 60s with small lymphocytic leukemia and BTK (Bruton tyrosine kinase)-…
 
Featuring perspectives from Drs Emmanuel Antonarakis and Daniel Petrylak, including the following topics: Introduction (0:00) Endocrine therapy (2:36) 177Lutetium-PSMA-617 (25:44) PARP inhibitors (35:55) Immunotherapy (49:06) CME information and select publicationsDr. Neil Love
 
Featuring perspectives from Professor Claire Harrison, including the following topics: Introduction (0:00) Case: A man in his early 70s with DIPSS low- to intermediate-risk post-essential thrombocythemia myelofibrosis (MF) — Warren S Brenner, MD (5:29) Case: A woman in her late 60s with primary MF who experiences disease progression after 3 years o…
 
Featuring perspectives from Dr Andrew Evens, including the following topics: Introduction (0:00) Case: A woman in her late 80s with Stage II classical Hodgkin lymphoma (HL) — Spencer Henick Bachow, MD (5:43) Case: A woman in her early 30s with sclerosing HL who achieved a complete response to ABVD — Priya Rudolph, MD, PhD (19:53) Case: A man in his…
 
Featuring perspectives from Dr Rami Komrokji, including the following topics: Introduction: Myelodysplastic Syndromes (MDS) Treatment Paradigm (0:00) Case: A man in his early 80s with MDS and multilineage dysplasia — Warren S Brenner, MD (14:15) Case: A man in his mid 50s with high-risk MDS and a TP53 mutation — Aleksander Chojecki, MD (25:03) Case…
 
Featuring a slide presentation and related discussion from Dr Judy Garber, including the following topics: PARP Inhibitors in Breast Cancer (0:00) OlympiA and NEOTALA Trials (12:03) Emerging Strategies with PARP Inhibitors in Breast Cancer (20:08) CME information and select publicationsDr. Neil Love
 
Featuring an interview with Dr Judy Garber, including the following topics: Applying the FDA indications for PARP inhibitors in breast cancer (0:00) Role of HRD (homologous recombination deficiency) and loss of heterozygosity in assessing patient risk; potential role for PARP inhibitors and other therapies for patients with mutations in genes other…
 
Loading …

Короткий довідник

Google login Twitter login Classic login